Selective and efficient retardation of cancers expressing cytoskeleton-associated protein 2 by targeted RNA replacement

International Journal of Cancer

Volumn 129, Issue 4, 2011, Pages 1018-1029

  Ban, Guyee ^a   Jeong, Jin Sook ^b   Kim, Areum ^a   Kim, Sung Jin ^a   Han, Sang Young ^b   Kim, In Hoo ^c   Lee, Seong Wook ^a  

^a Dankook University   (South Korea)

^b Dong A University   (South Korea)

^c National Cancer Center   (South Korea)

Author keywords

cancer gene therapy; CKAP2; RNA replacement; trans splicing ribozyme

Indexed keywords

ADENOVIRUS VECTOR; CELL PROTEIN; CYTOSKELETON ASSOCIATED PROTEIN 2; GANCICLOVIR; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); RIBOZYME; RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER REGRESSION; COLON CANCER; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG TARGETING; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CARCINOMA; LIVER TOXICITY; MALE; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RIBOZYME THERAPY; TRANS SPLICING; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CYTOSKELETAL PROTEINS; DRUG-INDUCED LIVER INJURY; GENE THERAPY; GENETIC VECTORS; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MICE; MICE, INBRED BALB C; NEOPLASMS; PHOSPHOENOLPYRUVATE CARBOXYLASE; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, CATALYTIC; RNA, MESSENGER; TRANS-SPLICING; TRANSGENES;

EID: 79959709823     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25988     Document Type: Article

References (37)

1. McCormick F,. Cancer gene therapy: fringe or cutting edge? Nat Rev Cancer 2001; 1: 130-41. (Pubitemid 33741888)
2. Wu L, Johnson M, Sato M,. Transcriptionally targeted gene therapy to detect and treat cancer. Trends Mol Med 2003; 9: 421-9. (Pubitemid 37309643)
3. Tarner IH, Muller-Ladner U, Fathman CG,. Targeted gene therapy: frontiers in the development of 'smart drugs'. Trends Biotechnol 2004; 22: 304-10. (Pubitemid 38639778)
4. Dorder DE, Nettelbeck DM,. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis. Adv Drug Deliv Rev 2009; 61: 554-71.
5. Maouche-Chretien L, Deleu N, Badoual C, Fraissignes P, Berger R, Gaulard P, Romeo PH, Leroy-Viard K,. Identification of a novel cDNA, encoding a cytoskeletal associated protein, differentially expressed in diffuse large B cell lymphomas. Oncogene 1998; 17: 1245-51. (Pubitemid 28446164)
6. Eichmuller S, Usener D, Dummer R, Stein A, Thiel D, Schadendorf D,. Serological detection of cutaneous T-cell lymphoma-associated antigen. Proc Natl Acad Sci USA 2001; 98: 629-34. (Pubitemid 32105094)
7. Bae CD, Sung YS, Jeon SM, Suh Y, Yang HK, Kim YI, Park KH, Choi J, Ahn G, Park J,. Up-regulation of cytoskeletal-associated protein 2 in primary human gastric adenocarcinomas. J Cancer Res Clin Oncol 2003; 129: 621-30. (Pubitemid 37452628)
8. Jeon SM, Choi B, Hong KU, Kim E, Seong YS, Bae CD, Park J,. A cytoskeleton-associated protein, TMAP/CKAP2, is involved in the proliferation of human foreskin fibroblasts. Biochem Biophys Res Commun 2006; 348: 222-8. (Pubitemid 44163503)
9. Jin Y, Murakumo Y, Ueno K, Hashimoto M, Watanabe T, Shimoyama Y, Ichihara M, Takahashi M,. Identification of a mouse cytoskeleton-associated protein, CKAP2, with microtubule-stabilizing properties. Cancer Sci 2004; 95: 815-21. (Pubitemid 39545588)
10. Hong KU, Park YS, Seong YS, Kand D, Bae CD, Park J,. Functional importance of the anaphase-promoting complex-Cdh1-mediated degradation of TMAP/CKAP2 in regulation of spindle function and cytokinesis. Mol Cell Biol 2007; 27: 3667-81. (Pubitemid 46726175)
11. Tsuchihara K, Lapin V, Bakal C, Okada H, Brown L, Hirota-Tsuchihara M, Zaugg K, Ho A, Itie-Youten A, Harris-Brandts M, Rottapel R, Richardson CD, et al. Ckap2 regulates aneuploidy, cell cycling and cell death in a p53-dependent manner. Cancer Res 2005; 65: 6685-91. (Pubitemid 41060705)
12. Hong KU, Kim E, Bae CD, Park J,. TMAP/CKAP2 is essential for proper chromosome segregation. Cell Cycle 2009; 8: 314-24.
13. Been M, Cech T,. One binding site determines sequence specificity of Tetrahymena pre-rRNA self-splicing, trans-splicing, and RNA enzyme activity. Cell 1986; 47: 207-16.
14. Sullenger BA, Cech TR,. Ribozyme-mediated repair of defective mRNA by targeted trans-splicing. Nature 1994; 317: 619-22. (Pubitemid 24315745)
15. Jones JT, Lee SW, Sullenger BA,. Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells. Nat Med 1996; 2: 643-8. (Pubitemid 26191950)
16. Lan N, Howrey RP, Lee SW, Smith CA, Sullenger BA,. Ribozyme-mediated repair of sickle β-globin mRNAs in erythrocyte precursors. Science 1998; 280: 1593-6. (Pubitemid 28277702)
17. Phylactou LA, Darrah C, Wood MAJ,. Ribozyme-mediated trans-splicing of a trinucleotide repeat. Nat Genet 1998; 18: 378-81. (Pubitemid 28158169)
18. Rogers CS, Vanoye CG, Sullenger BA, George AL,. Functional repair of a mutant chloride channel using a trans-splicing ribozyme. J Clin Invest 2002; 110: 1783-98.
19. Watanabe T, Sullenger BA,. Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts. Proc Natl Acad Sci USA 2000; 97: 8490-4. (Pubitemid 30639700)
20. Shin KS, Sullenger BA, Lee SW,. Ribozyme-mediated induction of apoptosis in human cancer cells by targeted repair of mutant p53 RNA. Mol Ther 2004; 10: 365-72. (Pubitemid 39117881)
21. Kastanos E, Hjiantoniou E, Phylactou LA,. Restoration of protein synthesis in pancreatic cancer cells by trans-splicing ribozymes. Biochem Biophys Res Commun 2004; 322: 930-4. (Pubitemid 39164442)
22. Ryu KJ, Kim JH, Lee SW,. Ribozyme-mediated selective induction of new gene activity in hepatitis C virus internal ribosome entry site-expressing cells by targeted trans-splicing. Mol Ther 2003; 7: 386-95.
23. Ryu KJ, Lee SW,. Comparative analysis of intracellular trans-splicing ribozyme activity against hepatitis C virus internal ribosome entry site. J Microbiol 2004; 42: 361-4.
24. Kwon BS, Jung HS, Song MS, Cho KS, Kim SC, Kim K, Jeong JS, Kim IH, Lee SW,. Specific regression of human cancer cells by ribozyme-mediated targeted replacement of tumor-specific transcript. Mol Ther 2005; 12: 824-34. (Pubitemid 41614477)
25. Hong SH, Jeong JS, Lee YJ, Jung HI, Cho KS, Kim CM, Kwon BS, Sullenger BA, Lee SW, Kim IH,. In vivo reprogramming of hTERT by trans-splicing ribozyme to target tumor cell. Mol Ther 2008; 16: 74-80.
26. Jeong JS, Lee SW, Hong SH, Lee YJ, Jung HI, Cho KS, Seo HH, Lee SJ, Park S, Song MS, Kim CM, Kim IH,. Antitumor effects of systemically delivered adenovirus harboring trans-splicing ribozyme in intrahepatic colon cancer mouse model. Clin Cancer Res 2008; 14: 281-90. (Pubitemid 351378004)
27. Song MS, Jeong JS, Ban G, Lee JH, Won YS, Cho KS, Kim IH, Lee SW,. Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo. Cancer Gene Ther 2009; 16: 113-25.
28. Giavazzi R, Jessup JM, Campbell DE, Walker SM, Fidler IJ,. Experimental nude mouse model of human colorectal cancer liver metastases. J Natl Cancer Inst 1986; 77: 1303-8. (Pubitemid 17005109)
29. Lee SJ, Lee SW, Jeong JS, Kim IH,. In vivo reprogramming of human telomerase reverse transcriptase (hTERT) by trans-splicing ribozyme to target tumor cells. Methods Mol Biol 2010; 629: 307-21.
30. Byun J, Lan N, Long M, Sullenger BA,. Efficient and specific repair of sickle beta-globin RNA by trans-splicing ribozymes. RNA 2003; 9: 1254-63. (Pubitemid 37151679)
31. Köhler U, Ayre BG, Goodman HM, Haseloff J,. Trans-splicing ribozymes for targeted gene delivery. J Mol Biol 1999; 285: 1935-50. (Pubitemid 29078162)
32. Kim A, Ban G, Song MS, Bae CD, Park J, Lee SW,. Selective regression of cells expressing mouse cytoskeleton-associated protein 2 transcript by trans-splicing ribozyme. Oligonucleotides 2007; 17: 95-103. (Pubitemid 46651431)
33. Song MS, Lee SW,. Cancer-selective induction of cytotoxicity by tissue-specific expression of targeted trans-splicing ribozyme. FEBS Lett 2006; 580: 5022-43.
34. Sagliocco FA, Vega Laso MR, Zhu D, Tuite MF, McCarthy JE, Brown AJ,. The influence of 5′-secondary structures upon ribosome binding to mRNA during translation in yeast. J Biol Chem 1993; 268: 26522-30. (Pubitemid 23361731)
35. Song MS, Jeong JS, Cho KS, Lee SW,. Gene expression responses in vivo by human telomerase reverse transcriptase (hTERT)-targeting trans-splicing ribozyme. Exp Mol Med 2007; 39: 722-32.
36. Song MS, Jeong JS, Lee SW,. Inhibition of telomerase expression in vivo by hTERT targeting trans-splicing ribozyme. J Nano Bio Tech 2008; 5: 13-17.
37. Mesnil M, Piccoli C, Tiraby G, Willecke K, Yamasaki H,. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexin. Proc Natl Acad Sci USA 1996; 93: 1831-5. (Pubitemid 26079840)